Role of FXR in the development of NAFLD and intervention strategies of small molecules
Authors:
- 2 May 2024
- journal article
- review article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 757, 110024
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou Municipal Science and Technology Program key projects (202201011420)
- National Natural Science Foundation of China (82274214)
This publication has 90 references indexed in Scilit:
- FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acidMedicinal Research Reviews, 2023
- Bile acids and their receptors: modulators and therapeutic targets in liver inflammationSeminars in Immunopathology, 2022
- Extract of Schisandra chinensis fruit protects against metabolic dysfunction in high‐fat diet induced obese mice via FXR activationPhytotherapy Research, 2020
- Nonalcoholic SteatohepatitisJAMA, 2020
- Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectivesJournal of Gastroenterology, 2019
- Antimicrobial proteins: intestinal guards to protect against liver diseaseJournal of Gastroenterology, 2018
- Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolismHepatology, 2018
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of diseaseHepatology, 2017
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaHepatology, 2015
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitisHepatology, 2010